Furthermore, D. officinale improved the risk of obesity-associated abnormal lipid metabolism and insulin resistance by enhancing the expression of PPAR-γ, which acts as a potent therapeutic agent for obesity-associated lipid metabolism disorder and insulin resistance (107). This evidence concerns the gene PPARG and Insulin resistance.